This HTML5 document contains 204 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n13http://dx.doi.org/10.1186/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n12https://scigraph.springernature.com/pub.10.1186/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q36449367
rdf:type
wikibase:Item
schema:description
مقالة علمية نشرت في عام 2008 2008年學術文章 2008년 논문 wissenschaftlicher Artikel artículo científico publicado en 2008 videnskabelig artikel (udgivet 2008) tudományos cikk 2008年学术文章 գիտական հոդված vedecký článok 2008年學術文章 artikulong pang-agham מאמר מדעי tieteellinen artikkeli artigo científico (publicado na 2008) bài báo khoa học 2008年学术文章 научная статья 2008 nî lūn-bûn наукова стаття, опублікована в січні 2008 wetenschappelijk artikel 2008年学术文章 vitenskapelig artikkel научни чланак artykuł naukowy scientific article научни чланак επιστημονικό άρθρο 2008年の論文 سائنسی مضمون articol științific مقالهٔ علمی мақолаи илмӣ vitskapeleg artikkel scienca artikolo 2008年學術文章 2008年学术文章 artigo científico (publicado na 2008) სამეცნიერო სტატია 2008年學術文章 mokslinis straipsnis 2008年學術文章 artikull shkencor article scientifique (publié 2008) article scientific bilimsel makale naučni članak teaduslik artikkel vědecký článek artículu científicu espublizáu en 2008 2008年学术文章 articolo scientifico научна статия 2008年學術文章 artigo científico article científic мақолаи илмӣ ২০০৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ บทความทางวิทยาศาสตร์ vetenskaplig artikel
p:P577
wds:Q36449367-F7A88BCB-0B3F-44BD-B16C-33EF12D0D9E6
wdt:P577
2008-01-08T00:00:00Z
p:P2888
wds:Q36449367-7B61E834-7A42-4415-94FE-26DB7C8826A0
wdt:P2888
n12:1479-5876-6-2
p:P2860
wds:Q36449367-87D8E1B3-AC06-4A14-B325-55FBD4E21AE1 wds:Q36449367-893A8954-AD2D-42B0-A47C-B5C8262515B7 wds:Q36449367-F809706D-51FD-4B5F-AA8F-D3C78543A4BF wds:Q36449367-F94E4BD3-E079-4953-AF37-AAE115905213 wds:Q36449367-D6B505D0-94D4-4D3C-9A3B-AE74B99888EF wds:Q36449367-EFCCDE86-1C28-45FF-BC88-6FA5FC6C63B5 wds:Q36449367-CC100C36-720F-4260-A1BE-27FB530C7831 wds:Q36449367-CF7051B8-9735-4EF9-984D-1AC90932A222 wds:Q36449367-D4090765-C579-456C-92C8-A580CFFD32DE wds:Q36449367-D433F7FD-EF30-4421-ADB4-3C9BE3AC00F4 wds:Q36449367-B3B5C2C8-5C71-4FD2-ACEE-45EA50CFC8B6 wds:Q36449367-BE300040-9CB8-4B2F-98D4-4964543D3112 wds:Q36449367-C1327845-826B-4340-9B28-9B3A53B7866E wds:Q36449367-C6FB0EAF-7116-49C0-91BF-A0F99CE88899 wds:Q36449367-05A9D09F-FCEB-42AF-9CF6-AD985DCE8DE9 wds:Q36449367-0ED2336D-A0FC-4D67-91AC-E8A5A5697D1C wds:Q36449367-1029D5D3-0472-4008-BE00-8D3F4095CEE8 wds:Q36449367-33961CF7-9579-4595-8737-71641CED3023 wds:Q36449367-3D022E85-8DAD-4198-94EE-8D0B5DDC30F0 wds:Q36449367-1F507AB6-7E30-4358-942C-D80EDB831F7D wds:Q36449367-7D549600-C863-4B62-85E5-252B1A7022F8 wds:Q36449367-800795D0-7E35-45CD-A5F6-FB69B8D8BCD7 wds:Q36449367-8256FAA1-F36D-48A6-8A74-2A3C64111CFC wds:Q36449367-844DBD0C-7B85-431C-AB2A-2017540C6D4B wds:Q36449367-5E5DEE84-032F-49EC-A7E1-62991025FA58 wds:Q36449367-66AD2776-72DF-4E88-B215-D105F6856B2D wds:Q36449367-50E28CE1-69F4-4ECF-90F7-2C5FF3AEDF8E wds:Q36449367-590C75B9-F40E-41BD-B010-5CB480CF63E0 wds:Q36449367-5ACBA431-62CC-4F04-86FF-4B611D8D9B35 wds:Q36449367-4EFE19F6-6E8A-461F-9B2E-92AC6510E933 wds:Q36449367-500B7EB9-EF52-4040-8B49-5D87B0B3C8F4 wds:Q36449367-AAF2C6B9-1463-4299-80BD-84D3216A386D wds:Q36449367-AC3A98FD-DC86-45FC-94B7-4A1CBA7B9F1B wds:Q36449367-AD0C2AB8-A827-4841-AD24-97F044284350 wds:Q36449367-A6E5EC87-FEAC-4D5E-8DAE-40565F74F24E wds:Q36449367-A918B023-906A-4960-913E-1C706BA90F5A wds:Q36449367-AA5230E8-AB68-4BE6-96A7-3FA3CFD555D9 wds:Q36449367-9354F001-5D64-4D97-AF09-CA679668B02F wds:Q36449367-96C91DAA-5614-468F-8AA3-EEF525001530 wds:Q36449367-A019FFB4-4A6F-4330-A81F-6F3C58D27309 wds:Q36449367-A1F796AB-AA81-437C-BCDD-D0DF46D4F69D wds:Q36449367-85D9F8FE-EB6C-481D-8644-1D1DBCB9CCEC
wdt:P2860
wd:Q73734066 wd:Q81766928 wd:Q43914944 wd:Q43955099 wd:Q73937318 wd:Q51776237 wd:Q44136733 wd:Q53921302 wd:Q33185774 wd:Q35035771 wd:Q77683561 wd:Q33963448 wd:Q35848435 wd:Q80185991 wd:Q35788112 wd:Q44235692 wd:Q46781781 wd:Q27860681 wd:Q35577243 wd:Q36024588 wd:Q28376841 wd:Q33185773 wd:Q35020524 wd:Q33371232 wd:Q24676378 wd:Q36373296 wd:Q31146869 wd:Q46711995 wd:Q61853687 wd:Q40514698 wd:Q43860650 wd:Q46859430 wd:Q80379759 wd:Q35748149 wd:Q79756124 wd:Q36374827 wd:Q28248186 wd:Q46296687 wd:Q34569946 wd:Q43704400 wd:Q51190015 wd:Q44861283
p:P2093
wds:Q36449367-A5B37759-0692-4068-BBF2-A2ECC7208117 wds:Q36449367-B1E165C2-18B9-486A-BF53-B4E5F0FB98A6 wds:Q36449367-899BCEFF-EA2F-4640-AE6A-8926B6034925 wds:Q36449367-4EB15B0E-EB26-48D2-8291-A413718DF356 wds:Q36449367-5BD3D3DB-9E25-45AD-B129-91929AF1BEAD wds:Q36449367-2A661599-43DB-4723-8C77-A74DC610CFA6 wds:Q36449367-28427724-B026-4245-85FD-25E029DDF178 wds:Q36449367-12D1884A-DC2A-4EB8-94A0-710C19358979 wds:Q36449367-1C33EBAE-1A4B-4AB9-9B3F-F2E45749338D
wdt:P2093
David O Holtz Phyllis A Gimotty Alisha Mohamed-Hadley Lin Zhang Wensheng Guo Ioannis Alagkiozidis George Coukos Robert T Krafty Benjamin Leiby
rdfs:label
Should tumor VEGF expression influence decisions on combining low-dose chemotherapy with antiangiogenic therapy? Preclinical modeling in ovarian cancer Should tumor VEGF expression influence decisions on combining low-dose chemotherapy with antiangiogenic therapy? Preclinical modeling in ovarian cancer Should tumor VEGF expression influence decisions on combining low-dose chemotherapy with antiangiogenic therapy? Preclinical modeling in ovarian cancer
skos:prefLabel
Should tumor VEGF expression influence decisions on combining low-dose chemotherapy with antiangiogenic therapy? Preclinical modeling in ovarian cancer Should tumor VEGF expression influence decisions on combining low-dose chemotherapy with antiangiogenic therapy? Preclinical modeling in ovarian cancer Should tumor VEGF expression influence decisions on combining low-dose chemotherapy with antiangiogenic therapy? Preclinical modeling in ovarian cancer
schema:name
Should tumor VEGF expression influence decisions on combining low-dose chemotherapy with antiangiogenic therapy? Preclinical modeling in ovarian cancer Should tumor VEGF expression influence decisions on combining low-dose chemotherapy with antiangiogenic therapy? Preclinical modeling in ovarian cancer Should tumor VEGF expression influence decisions on combining low-dose chemotherapy with antiangiogenic therapy? Preclinical modeling in ovarian cancer
p:P1476
wds:Q36449367-17CAB7AB-EBBF-4B43-B941-CD8AA0B6E5EB
wdt:P1476
Should tumor VEGF expression influence decisions on combining low-dose chemotherapy with antiangiogenic therapy? Preclinical modeling in ovarian cancer
p:P304
wds:Q36449367-DD7271FE-514D-456E-AFA2-ED2631B276CD
wdt:P304
2
p:P31
wds:Q36449367-50AB76BD-F5DA-4D29-AB64-B86CEF4582A2
wdt:P31
wd:Q13442814
p:P921
wds:Q36449367-2274FD1C-A9F9-42B1-B801-BFA8CEF3AAF8 wds:Q36449367-296FB380-2930-4637-AD06-EB6359EEA6C4 wds:Q36449367-3065D756-1480-4E69-8919-5645E6BA3EC8
wdt:P921
wd:Q574834 wd:Q172341 wd:Q974135
p:P698
wds:Q36449367-63EDF296-511B-41E0-9D74-1E5399B6E251
wdtn:P698
n10:18182107
wdt:P698
18182107
p:P1433
wds:Q36449367-14CDDE7F-D40C-45A2-AA55-C0F8B4E28E6D
wdt:P1433
wd:Q15716664
p:P478
wds:Q36449367-20DD7B15-6B18-496B-8E4C-6AC505EF55D6
wdt:P478
6
p:P356
wds:Q36449367-024F5485-32E7-4511-B210-DE3638FC17FD
wdtn:P356
n13:1479-5876-6-2
wdt:P356
10.1186/1479-5876-6-2
p:P5875
wds:Q36449367-11A09ECC-FA08-4FE9-999D-763DFDCAD81F
wdt:P5875
26499494
p:P6179
wds:Q36449367-2D498AF8-1909-485D-A7A0-3EB01FDCA82B
wdt:P6179
1034847150
p:P932
wds:Q36449367-41C8DBD2-566D-4383-BCB4-3AFE5C3E93DD
wdt:P932
2235830